Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis

Carl Owen, Alicja Czopek, Abdelali Agouni, Louise Grant, Robert Judson, Emma K Lees, George D McIlroy, Olga Göransson, Andy Welch, Kendra K Bence, Barbara B Kahn, Benjamin G Neel, Nimesh Mody, Mirela Delibegovic

Research output: Contribution to journalArticle

44 Citations (Scopus)
5 Downloads (Pure)

Abstract

Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin and
insulin signaling, is positively correlated with adiposity and contributes to insulin
resistance. Global PTP1B deletion improves diet-induced obesity and glucose
homeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B-/-) were generated using the adiponectin-promoter to drive Crerecombinase expression. Chow-fed adip-crePTP1B-/- mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B-/- mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxiainduced factor-1-alpha (Hif-1a) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.
Original languageEnglish
Article numbere32700
Number of pages15
JournalPloS ONE
Volume7
Issue number2
Early online date27 Feb 2012
DOIs
Publication statusPublished - 28 Feb 2012

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
protein-tyrosine-phosphatase
Lipogenesis
lipogenesis
adipocytes
Cell Size
Adipocytes
homeostasis
Homeostasis
Glucose
glucose
Leptin
leptin
Adiposity
adiposity
cells
Insulin Receptor
Nutrition
mice
Body Weight

Cite this

Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. / Owen, Carl; Czopek, Alicja; Agouni, Abdelali; Grant, Louise; Judson, Robert; Lees, Emma K; McIlroy, George D; Göransson, Olga ; Welch, Andy; Bence, Kendra K; Kahn, Barbara B; Neel, Benjamin G; Mody, Nimesh; Delibegovic, Mirela.

In: PloS ONE, Vol. 7, No. 2, e32700, 28.02.2012.

Research output: Contribution to journalArticle

Owen, Carl ; Czopek, Alicja ; Agouni, Abdelali ; Grant, Louise ; Judson, Robert ; Lees, Emma K ; McIlroy, George D ; Göransson, Olga ; Welch, Andy ; Bence, Kendra K ; Kahn, Barbara B ; Neel, Benjamin G ; Mody, Nimesh ; Delibegovic, Mirela. / Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. In: PloS ONE. 2012 ; Vol. 7, No. 2.
@article{26e2bcc4ff96457c8afb90463f57dd8a,
title = "Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis",
abstract = "Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin andinsulin signaling, is positively correlated with adiposity and contributes to insulinresistance. Global PTP1B deletion improves diet-induced obesity and glucosehomeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B-/-) were generated using the adiponectin-promoter to drive Crerecombinase expression. Chow-fed adip-crePTP1B-/- mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B-/- mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxiainduced factor-1-alpha (Hif-1a) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.",
author = "Carl Owen and Alicja Czopek and Abdelali Agouni and Louise Grant and Robert Judson and Lees, {Emma K} and McIlroy, {George D} and Olga G{\"o}ransson and Andy Welch and Bence, {Kendra K} and Kahn, {Barbara B} and Neel, {Benjamin G} and Nimesh Mody and Mirela Delibegovic",
year = "2012",
month = "2",
day = "28",
doi = "10.1371/journal.pone.0032700",
language = "English",
volume = "7",
journal = "PloS ONE",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY SCIENCE",
number = "2",

}

TY - JOUR

T1 - Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis

AU - Owen, Carl

AU - Czopek, Alicja

AU - Agouni, Abdelali

AU - Grant, Louise

AU - Judson, Robert

AU - Lees, Emma K

AU - McIlroy, George D

AU - Göransson, Olga

AU - Welch, Andy

AU - Bence, Kendra K

AU - Kahn, Barbara B

AU - Neel, Benjamin G

AU - Mody, Nimesh

AU - Delibegovic, Mirela

PY - 2012/2/28

Y1 - 2012/2/28

N2 - Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin andinsulin signaling, is positively correlated with adiposity and contributes to insulinresistance. Global PTP1B deletion improves diet-induced obesity and glucosehomeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B-/-) were generated using the adiponectin-promoter to drive Crerecombinase expression. Chow-fed adip-crePTP1B-/- mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B-/- mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxiainduced factor-1-alpha (Hif-1a) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.

AB - Protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of leptin andinsulin signaling, is positively correlated with adiposity and contributes to insulinresistance. Global PTP1B deletion improves diet-induced obesity and glucosehomeostasis via enhanced leptin signaling in the brain and increased insulin signaling in liver and muscle. However, the role of PTP1B in adipocytes is unclear, with studies demonstrating beneficial, detrimental or no effect(s) of adipose-PTP1B-deficiency on body mass and insulin resistance. To definitively establish the role of adipocyte-PTP1B in body mass regulation and glucose homeostasis, adipocyte-specific-PTP1B knockout mice (adip-crePTP1B-/-) were generated using the adiponectin-promoter to drive Crerecombinase expression. Chow-fed adip-crePTP1B-/- mice display enlarged adipocytes, despite having similar body weight/adiposity and glucose homeostasis compared to controls. High-fat diet (HFD)-fed adip-crePTP1B-/- mice display no differences in body weight/adiposity but exhibit larger adipocytes, increased circulating glucose and leptin levels, reduced leptin sensitivity and increased basal lipogenesis compared to controls. This is associated with decreased insulin receptor (IR) and Akt/PKB phosphorylation, increased lipogenic gene expression and increased hypoxiainduced factor-1-alpha (Hif-1a) expression. Adipocyte-specific PTP1B deletion does not beneficially manipulate signaling pathways regulating glucose homeostasis, lipid metabolism or adipokine secretion in adipocytes. Moreover, PTP1B does not appear to be the major negative regulator of the IR in adipocytes.

U2 - 10.1371/journal.pone.0032700

DO - 10.1371/journal.pone.0032700

M3 - Article

VL - 7

JO - PloS ONE

JF - PloS ONE

SN - 1932-6203

IS - 2

M1 - e32700

ER -